Presentation
14 March 2023 Near-infrared II photobiomodulation augments nitric oxide bioavailability via phosphorylation of endothelial nitric oxide synthase (Conference Presentation)
Author Affiliations +
Proceedings Volume 12380, Biophotonics and Immune Responses XVIII; 1238007 (2023) https://doi.org/10.1117/12.2646735
Event: SPIE BiOS, 2023, San Francisco, California, United States
Abstract
There is solid evidence of diverse beneficial effects of the treatment with low-power near-infrared (NIR) light in the NIR I window (630-900 nm). We have demonstrated PBM with NIR-II window (1061-1301 nm) augments the immune response of the vaccine, but other beneficial effects of NIR-II laser have not been fully explored. In this study, we have shown that NIR-II laser enhances bioavailable NO in endothelial cells. Since a hallmark of endothelial dysfunction is suppressed eNOS with concomitant NO deficiency, NIR-II laser technology could be broadly used to restore endothelial NO and treat or prevent cardiovascular diseases.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Shinya Yokomizo, Dmitriy N. Atochin, and Satoshi Kashiwagi "Near-infrared II photobiomodulation augments nitric oxide bioavailability via phosphorylation of endothelial nitric oxide synthase (Conference Presentation)", Proc. SPIE 12380, Biophotonics and Immune Responses XVIII, 1238007 (14 March 2023); https://doi.org/10.1117/12.2646735
Advertisement
Advertisement
KEYWORDS
NOx

Near infrared

Laser applications

Luminescence

Skin

Solids

Back to Top